Cargando…
NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay
Background: DNA extracellular traps (ETs), released by neutrophils (NETs), or eosinophils (EETs), play a pathogenic role in several autoimmune disorders. However, to date, NETs have never been investigated in bullous pemphigoid (BP) with respect to clinical and immunological activities, both at base...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458298/ https://www.ncbi.nlm.nih.gov/pubmed/31019514 http://dx.doi.org/10.3389/fimmu.2019.00701 |
_version_ | 1783409981637263360 |
---|---|
author | Giusti, Delphine Bini, Estela Terryn, Christine Didier, Kevin Le Jan, Sébastien Gatouillat, Grégory Durlach, Anne Nesmond, Stéphane Muller, Celine Bernard, Philippe Antonicelli, Frank Pham, Bach Nga |
author_facet | Giusti, Delphine Bini, Estela Terryn, Christine Didier, Kevin Le Jan, Sébastien Gatouillat, Grégory Durlach, Anne Nesmond, Stéphane Muller, Celine Bernard, Philippe Antonicelli, Frank Pham, Bach Nga |
author_sort | Giusti, Delphine |
collection | PubMed |
description | Background: DNA extracellular traps (ETs), released by neutrophils (NETs), or eosinophils (EETs), play a pathogenic role in several autoimmune disorders. However, to date, NETs have never been investigated in bullous pemphigoid (BP) with respect to clinical and immunological activities, both at baseline and at time of relapse which have been characterized with specific IL-17 and IL-23 patterns. Objective: We sought to assess whether ETs were associated with BP as well as the relative contribution of IL-17 axis cytokines to NET induction. Methods: Skin biopsy specimens were obtained from 11 patients with BP. Immuno-detection of neutrophils and eosinophils combined to DNA staining allowed us to investigate the in-situ presence of NETs and EETs using confocal scanning microscopy. NETs release was evaluated ex vivo by stimulating polymorphonuclear cells from BP patients with BP biological fluids in presence of IL-17A and IL-23 or of glucocorticoids. Results: At baseline, ETs were observed in BP lesions at the site of dermal-epidermal cleavage. Despite an important infiltrate of eosinophils, ETs were essentially associated with neutrophils in situ and were not related to BP clinical activity at diagnosis. In situ observation of NETs was associated in 6 among 8 patients with serum capacity of NET induction. Notably both blister fluid and sera from BP patients at diagnosis and at time of relapse could induce NET formation ex vivo. In contrast, a longitudinal investigation showed a decrease of NET formation with time of treatment in patients undergoing remission. Mimicking relapse, complementation of sera from BP patients with ongoing remission with either IL-17A or IL-23 increased NET formation. Conversely, IL-17A inhibited NET formation induced by serum from BP patients with relapse supplemented or not with IL-23. Finally, glucocorticoids also inhibited NET formation ex vivo in BP. Conclusion: NET formation is an associated phenomenon with BP. Furthermore, we showed that IL-23 favored NET formation, whereas the effects of IL-17A are environment dependent. Indeed, IL-17A displayed a protective effect on NET formation when associated with IL-23, showing for the first-time differential effects of these two cytokines in BP. |
format | Online Article Text |
id | pubmed-6458298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64582982019-04-24 NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay Giusti, Delphine Bini, Estela Terryn, Christine Didier, Kevin Le Jan, Sébastien Gatouillat, Grégory Durlach, Anne Nesmond, Stéphane Muller, Celine Bernard, Philippe Antonicelli, Frank Pham, Bach Nga Front Immunol Immunology Background: DNA extracellular traps (ETs), released by neutrophils (NETs), or eosinophils (EETs), play a pathogenic role in several autoimmune disorders. However, to date, NETs have never been investigated in bullous pemphigoid (BP) with respect to clinical and immunological activities, both at baseline and at time of relapse which have been characterized with specific IL-17 and IL-23 patterns. Objective: We sought to assess whether ETs were associated with BP as well as the relative contribution of IL-17 axis cytokines to NET induction. Methods: Skin biopsy specimens were obtained from 11 patients with BP. Immuno-detection of neutrophils and eosinophils combined to DNA staining allowed us to investigate the in-situ presence of NETs and EETs using confocal scanning microscopy. NETs release was evaluated ex vivo by stimulating polymorphonuclear cells from BP patients with BP biological fluids in presence of IL-17A and IL-23 or of glucocorticoids. Results: At baseline, ETs were observed in BP lesions at the site of dermal-epidermal cleavage. Despite an important infiltrate of eosinophils, ETs were essentially associated with neutrophils in situ and were not related to BP clinical activity at diagnosis. In situ observation of NETs was associated in 6 among 8 patients with serum capacity of NET induction. Notably both blister fluid and sera from BP patients at diagnosis and at time of relapse could induce NET formation ex vivo. In contrast, a longitudinal investigation showed a decrease of NET formation with time of treatment in patients undergoing remission. Mimicking relapse, complementation of sera from BP patients with ongoing remission with either IL-17A or IL-23 increased NET formation. Conversely, IL-17A inhibited NET formation induced by serum from BP patients with relapse supplemented or not with IL-23. Finally, glucocorticoids also inhibited NET formation ex vivo in BP. Conclusion: NET formation is an associated phenomenon with BP. Furthermore, we showed that IL-23 favored NET formation, whereas the effects of IL-17A are environment dependent. Indeed, IL-17A displayed a protective effect on NET formation when associated with IL-23, showing for the first-time differential effects of these two cytokines in BP. Frontiers Media S.A. 2019-04-04 /pmc/articles/PMC6458298/ /pubmed/31019514 http://dx.doi.org/10.3389/fimmu.2019.00701 Text en Copyright © 2019 Giusti, Bini, Terryn, Didier, Le Jan, Gatouillat, Durlach, Nesmond, Muller, Bernard, Antonicelli and Pham. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Giusti, Delphine Bini, Estela Terryn, Christine Didier, Kevin Le Jan, Sébastien Gatouillat, Grégory Durlach, Anne Nesmond, Stéphane Muller, Celine Bernard, Philippe Antonicelli, Frank Pham, Bach Nga NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay |
title | NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay |
title_full | NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay |
title_fullStr | NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay |
title_full_unstemmed | NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay |
title_short | NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay |
title_sort | net formation in bullous pemphigoid patients with relapse is modulated by il-17 and il-23 interplay |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458298/ https://www.ncbi.nlm.nih.gov/pubmed/31019514 http://dx.doi.org/10.3389/fimmu.2019.00701 |
work_keys_str_mv | AT giustidelphine netformationinbullouspemphigoidpatientswithrelapseismodulatedbyil17andil23interplay AT biniestela netformationinbullouspemphigoidpatientswithrelapseismodulatedbyil17andil23interplay AT terrynchristine netformationinbullouspemphigoidpatientswithrelapseismodulatedbyil17andil23interplay AT didierkevin netformationinbullouspemphigoidpatientswithrelapseismodulatedbyil17andil23interplay AT lejansebastien netformationinbullouspemphigoidpatientswithrelapseismodulatedbyil17andil23interplay AT gatouillatgregory netformationinbullouspemphigoidpatientswithrelapseismodulatedbyil17andil23interplay AT durlachanne netformationinbullouspemphigoidpatientswithrelapseismodulatedbyil17andil23interplay AT nesmondstephane netformationinbullouspemphigoidpatientswithrelapseismodulatedbyil17andil23interplay AT mullerceline netformationinbullouspemphigoidpatientswithrelapseismodulatedbyil17andil23interplay AT bernardphilippe netformationinbullouspemphigoidpatientswithrelapseismodulatedbyil17andil23interplay AT antonicellifrank netformationinbullouspemphigoidpatientswithrelapseismodulatedbyil17andil23interplay AT phambachnga netformationinbullouspemphigoidpatientswithrelapseismodulatedbyil17andil23interplay |